Around Fox Chase

Sanjeevani Arora, PhD, Assistant Professor for the Cancer Prevention and Control Research Program at Fox Chase Cancer Center, has been appointed to the National Institutes of Health (NIH) Basic Mechanisms of Cancer Health Disparities Study Section

Jessica Bauman, MD, Chief of the Division of Head and Neck Medical Oncology at Fox Chase Cancer Center and the Program Director of the Hematology-Oncology Fellowship at Fox Chase/Temple University Health System, has been named a Fellow of the American Society of Clinical Oncology (FASCO).

Jeffrey Farma, MD, FACS, the Paul Grotzinger and Wilbur Raab Chair in Surgical Oncology at Fox Chase Cancer Center, has been named a member of the American College of Surgeons (ACS) Academy of Master Surgeon Educators, an honor recognizing sustained excellence and leadership in surgical education.

Jonathan Chernoff, MD, PhD, the Stanley P. Reimann Chair in Oncology Research at Fox Chase Cancer Center, has received a Drug Discovery Initiative Award from the Children’s Tumor Foundation to pursue a new strategy for targeting RAS biology in neurofibromatosis type 1, or NF1.

Colleen Hogan Tetzlaff, MHS, PA-C, a physician assistant (PA) in the Division of Genitourinary Medical Oncology at Fox Chase Cancer Center, has received the 2026 Lifetime Achievement Award from the Association of PAs in Oncology (APAO).

The sixth annual Cancer Epigenetics Institute (CEI) Symposium celebrated the 5th birthday of CEI. The event brought together more than 750 scientists, clinicians, trainees and industry leaders from 20 countries to showcase the latest discoveries in epigenetics and their potential to improve cancer care.

Dr. Robert A. Winn helped launch the Executive Leadership Academy for Cancer Centers during his tenure as director of VCU Massey. The initiative is an 18-month academy curriculum designed for individuals interested in learning more about the Cancer Center Support Grant and aspiring to become future leaders of NCI-designated cancer centers.

A new nationally funded research project led by Hayan Lee, PhD, an Assistant Professor and member of the Cancer Epigenetics Institute at Fox Chase Cancer Center, aims to help answer that question by studying how changes in our DNA over time influence aging and inflammation.